News Search Filter :
 
From Date :
   
To Date :
   
Results Per Page:

 
Company Search:
 
Company Name:
Symbol Lookup:
Results Per Page:
 

You are not registered on World Stock Wire.
[ Sign up for a Free Account ] [ Log in ]

Adoodle, Inc (ADDE), USA
2009-06-25 08:05:46 EST

NOXO Autism Aid Balm From Adoodle Available In September Helps Settle Brain Waves And Behavioral Patterns Back To Normal

Wynnewood, PA - (WORLD STOCK WIRE) - June 25, 2009 -- Adoodle, Inc, (OTC Pink Sheets: ADDE) announced today that NOXO Autism Aid balm will be available in September at a price of $ 1 per dose at retail stores and the Internet.

The new NOXO Autism Aid balm, when applied topically, under the nostrils helps settle brain waves and behavioral patterns back to normal by sending scent molecules into an autistic child’s system where they entirely bypass the brain-blood barrier and move directly to the brain's olfactory nerves. These tiny hair-like nerves that capture the aroma of NOXO essential oil molecules, transports their "messages" directly to the brain's limbic system which controls emotion.

NOXO Autism Aid has the ability to detoxify and oxygenate the body, something that research has been found to help these special children by making them calmer, happier, relaxed, quieter with a feeling of well being.

NOXO Autism Aid balm, a proprietary product formula of 14 unique all natural ingredients, which are soy-based, is absorbed into the skin and is not visible after application. Invented by Dr. V. Ruth Pinney and based on olfactory perception altering technology, the NOXO line of products is focused on modifying behavior, via the olfactory senses.

About Adoodle

Adoodle’s NOXO division is focused to develop a variety of products that can modify behavior, via olfactory senses, such as smoking cessation, autism, or weight control, as examples. The company's first product to reach commercialization is called NOXO Anti-Odor, which has the ability to alter the brains ability to smell horrific odors. The odor is still there and it's not masked. The brain does not however, register its normal reaction to it. The uniquely formulated NOXO is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney who is a director of Adoodle and who also directs the research at the company's new research center in The Woodlands, Texas.

For dealer and inquiries, please complete our online inquiry form at: www.noxoinfo.com/contact.html

NOXO product information can also be found at: www.noxoinfo.com or by calling: 1- 888-383-1743; email: support@noxoinfo.com

Investors & Media Relations:
WSMG -
Tel: 760-329-4169 or 888-383-1743
email: adde@wsmg.biz

Safe Harbor for Public Companies
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Adoodle, "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Adoodle website as they become available.





Richard Stevenson
Adoodle, Inc
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 19096
USA

Phone: 888-383-1743


Note: The following news is from Adoodle, Inc, and World Stock Wire, Inc. is not liable for the contents of this news.